Quince Therapeutics Inc

QNCXNASDAQ · USD
31.00USD+29.75 (+3.34%)
112

Quince Therapeutics Inc (QNCX) Option Chain

As of September 25, 2026, Quince Therapeutics Inc is trading at $31.00, a +3.34% change from the previous close. The nearest expiration is —. Implied volatility is 520.1%. IV Rank is 84%.

Read more

Tracking the QNCX option chain helps you see every strike and expiry on Quince Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Quince Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of QNCX options activity at a glance. Use our scanner to monitor the QNCX option chain in real time and filter for the QNCX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For QNCX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the QNCX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where QNCX stock options are being actively traded and where they are not.

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Quince Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen QNCX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of QNCX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile9.13% Subdued
  • Market cap (M$)7
  • 52 weeks high-97.32%
  • 52 weeks low52.50%
  • Analyst recommendationHold
    3.40
  • Target price$55.00
    77.42% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-05-12
  • P/E—
  • Future P/E—
  • EPS (ttm)-16.43
  • EPS growth next 5 years—

As of September 25, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
No option chain data available.

As of September 25, 2026

Scan the full option chain in one place

Browse the full QNCX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial